Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of targeted drugs are currently available, including lebrikizumab, dupilumab, and ...

Generally speaking, when someone has Type 1 diabetes, their blood contains a marker – called islet autoantibodies – that ...

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.

An international team of researchers has made a key discovery: many children and young adults in Sub-Saharan Africa diagnosed ...

In addition to cutting candy and carbs, people at risk for diabetes need to avoid other foods that are bad for blood sugar and health. Here are some to watch for.

In The Lancet Diabetes & Endocrinology, Jean Claude Katte and colleagues report the results of the cross-sectional ...

Download Free Sample of This Strategic Report with Industry Analysis @ The autoimmune disease drug market in Saudi Arabia is a dynamic sector witnessing steady growth driven by increasing prevalence ...

Discover a study uncovering how JAK inhibitors protect against autoimmune diabetes triggered by cancer immunotherapy.